Option Care Health’s (OPCH) “Overweight” Rating Reiterated at Morgan Stanley

Morgan Stanley reaffirmed their overweight rating on shares of Option Care Health (NASDAQ:OPCH) in a research report sent to investors on Wednesday morning,Benzinga reports.

Other equities research analysts also recently issued research reports about the company. Barrington Research dropped their price objective on Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research report on Tuesday, January 13th. Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price objective on the stock. in a research report on Friday, May 1st. JPMorgan Chase & Co. dropped their price objective on Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a research report on Monday, May 4th. Finally, National Bank Financial set a $37.00 price objective on Option Care Health in a research report on Tuesday, January 27th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $31.25.

Option Care Health Price Performance

OPCH opened at $20.51 on Wednesday. Option Care Health has a 12-month low of $18.01 and a 12-month high of $36.80. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. The business’s fifty day simple moving average is $28.29 and its 200-day simple moving average is $30.61. The company has a market capitalization of $3.22 billion, a price-to-earnings ratio of 15.90, a PEG ratio of 1.14 and a beta of 0.68.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.39 billion. During the same quarter in the prior year, the company earned $0.40 EPS. The business’s revenue was up 1.3% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, equities research analysts anticipate that Option Care Health will post 1.65 earnings per share for the current fiscal year.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, CEO John Charles Rademacher purchased 12,500 shares of the firm’s stock in a transaction on Monday, May 4th. The stock was bought at an average cost of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the purchase, the chief executive officer owned 695,152 shares in the company, valued at $14,723,319.36. This represents a 1.83% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,610 shares of Option Care Health stock in a transaction dated Monday, May 4th. The stock was purchased at an average price of $21.41 per share, with a total value of $783,820.10. Following the completion of the purchase, the director owned 450,000 shares of the company’s stock, valued at approximately $9,634,500. The trade was a 8.86% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders acquired 73,264 shares of company stock worth $1,548,316. 1.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of OPCH. Victory Capital Management Inc. raised its position in Option Care Health by 129.5% during the third quarter. Victory Capital Management Inc. now owns 383,605 shares of the company’s stock valued at $10,649,000 after acquiring an additional 216,489 shares in the last quarter. Geneva Capital Management LLC raised its position in Option Care Health by 27.6% during the third quarter. Geneva Capital Management LLC now owns 1,369,862 shares of the company’s stock valued at $38,027,000 after acquiring an additional 296,216 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in Option Care Health by 2.7% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,244,321 shares of the company’s stock valued at $34,542,000 after acquiring an additional 33,019 shares in the last quarter. Game Creek Capital LP purchased a new position in Option Care Health during the third quarter valued at approximately $1,527,000. Finally, Tredje AP fonden purchased a new position in Option Care Health during the third quarter valued at approximately $1,018,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

More Option Care Health News

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: Director Timothy P. Sullivan bought 24,154 shares for about $500,000, boosting his ownership by 49%, which investors may view as a confidence signal from management. Sullivan SEC Filing
• Positive Sentiment: Analyst sentiment remains constructive overall, with the consensus still at “Moderate Buy,” and Morgan Stanley reaffirmed an “Overweight” rating. Analyst Recommendation
• Neutral Sentiment: The company is drawing attention ahead of its appearance at the Bank of America Health Care Conference, which could provide more color on execution and guidance. Conference Notice
• Negative Sentiment: Multiple law firms launched securities-fraud investigations and shareholder-loss alerts after Option Care Health’s weaker-than-expected Q1 results and reduced outlook, adding legal and reputational overhang. Holzer Alert
• Negative Sentiment: Q1 earnings were mixed: EPS beat estimates, but revenue missed and management lowered full-year revenue guidance, fueling concerns about slowing growth and future execution. Earnings and Guidance

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.